ADORA2A and schizophrenia: While this combination of α2-AR and D2 receptor antagonism presents with improved antipsychotic-like effects in mouse models of schizophrenia, it also resulted in enhanced cortical glutamatergic transmission and increased dopaminergic output in the PFC, with subsequent improvement in cognitive parameters in rats (84).